Explore more publications!
Tech News St. Vincent & Grenadines
Got News to Share?

Tech News St. Vincent & Grenadines: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech News St. Vincent & Grenadines.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 23, 2025

Datavault AI Inc מודיעה על קבלת אישור לשני פטנטים מרכזיים בארצות הברית המקדמים רישוי תוכן מבוסס בלוקצ'יין ומוינטיזציה מבוססת אסימונים
December 23, 2025

Datavault AI Inc מודיעה על קבלת אישור לשני פטנטים מרכזיים בארצות הברית המקדמים רישוי תוכן מבוסס בלוקצ'יין ומוינטיזציה מבוססת אסימונים

Indeterminate GlobeNewswire
Datavault AI Inc. Mengumumkan Pengeluaran Dua Paten Asas di A.S. yang Memajukan Pelesenan Kandungan Dipacu Blockchain serta Pengewangan yang Ditokenisasi
December 23, 2025

Datavault AI Inc. Mengumumkan Pengeluaran Dua Paten Asas di A.S. yang Memajukan Pelesenan Kandungan Dipacu Blockchain serta Pengewangan yang Ditokenisasi

Indeterminate GlobeNewswire
Roadzen to Showcase DrivebuddyAI as First-Time Exhibitor at CES 2026 (January 6 – 9)
December 23, 2025

Roadzen to Showcase DrivebuddyAI as First-Time Exhibitor at CES 2026 (January 6 – 9)

Indeterminate GlobeNewswire
Jet.AI Inc. JV for 50MW Data Center Campus in Moapa, Nevada
December 23, 2025

Jet.AI Inc. JV for 50MW Data Center Campus in Moapa, Nevada

Indeterminate GlobeNewswire
Press Release: Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia
December 23, 2025

Press Release: Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia

Indeterminate GlobeNewswire
Communiqué de presse : Wayrilz de Sanofi approuvé dans l’UE comme premier inhibiteur de la BTK pour le traitement de la thrombocytopénie immunitaire (TPI)
December 23, 2025

Communiqué de presse : Wayrilz de Sanofi approuvé dans l’UE comme premier inhibiteur de la BTK pour le traitement de la thrombocytopénie immunitaire (TPI)

Indeterminate GlobeNewswire
iPower Enters into Strategic $30 Million Financing Facility to Strengthen Balance Sheet and Launch Digital Asset Treasury
December 23, 2025

iPower Enters into Strategic $30 Million Financing Facility to Strengthen Balance Sheet and Launch Digital Asset Treasury

Indeterminate GlobeNewswire
NordProtect adds new monitoring features to alert users on fraudulent activities
December 23, 2025

NordProtect adds new monitoring features to alert users on fraudulent activities

Indeterminate GlobeNewswire
Kailera Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference
December 23, 2025

Kailera Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Sleep.ai Joins National Sleep Foundation’s SleepTech® Network
December 23, 2025

Sleep.ai Joins National Sleep Foundation’s SleepTech® Network

Indeterminate GlobeNewswire
Scilex Holding Company Confirms Dream Bowl 2026 Meme Coin Claim Process on December 24, 2025 Drop by Datavault AI Inc.
December 23, 2025

Scilex Holding Company Confirms Dream Bowl 2026 Meme Coin Claim Process on December 24, 2025 Drop by Datavault AI Inc.

Indeterminate GlobeNewswire
Greenridge Global: Positive Developments At Society Pass Inc. (Nasdaq: SOPA) Overlooked By The Market
December 23, 2025

Greenridge Global: Positive Developments At Society Pass Inc. (Nasdaq: SOPA) Overlooked By The Market

Indeterminate GlobeNewswire
Artelo Bioscience Commends Presidential Executive Order Expanding CBD Research and Access; Highlights ART12.11 as a Leading Pharmaceutical-Grade Cannabidiol Candidate
December 23, 2025

Artelo Bioscience Commends Presidential Executive Order Expanding CBD Research and Access; Highlights ART12.11 as a Leading Pharmaceutical-Grade Cannabidiol Candidate

Indeterminate GlobeNewswire
Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates
December 23, 2025

Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates

Indeterminate GlobeNewswire
Entera Bio Congratulates the FNIH-ASBMR-SABRE Team on FDA’s Qualification of Total Hip BMD as Regulatory Endpoint: Huge Win for Osteoporosis Innovation
December 23, 2025

Entera Bio Congratulates the FNIH-ASBMR-SABRE Team on FDA’s Qualification of Total Hip BMD as Regulatory Endpoint: Huge Win for Osteoporosis Innovation

Indeterminate GlobeNewswire
VisionWave Announces Issuance of New U.S. Patent, Expanding Enforceable Protection Across Its Core RF Imaging and AI Platform
December 23, 2025

VisionWave Announces Issuance of New U.S. Patent, Expanding Enforceable Protection Across Its Core RF Imaging and AI Platform

Indeterminate GlobeNewswire
DriveItAway Holdings Ignites National Scale with Free2move and Launches 9 New Cities in December
December 23, 2025

DriveItAway Holdings Ignites National Scale with Free2move and Launches 9 New Cities in December

Indeterminate GlobeNewswire
Akari Therapeutics Initiates GMP Manufacturing of AKTX-101 ADC Program to Support Phase 1 First-in-Human Clinical Trial
December 23, 2025

Akari Therapeutics Initiates GMP Manufacturing of AKTX-101 ADC Program to Support Phase 1 First-in-Human Clinical Trial

Indeterminate GlobeNewswire
Versus Systems Executes Definitive Agreement with Drinkfinger to Power Global Beverage Engagement Network
December 23, 2025

Versus Systems Executes Definitive Agreement with Drinkfinger to Power Global Beverage Engagement Network

Indeterminate GlobeNewswire
Inspira Technologies Reaffirms $49.5 Million in Binding Purchase Orders and Aligns Execution with 2026 Regulatory and Deployment Milestones
December 23, 2025

Inspira Technologies Reaffirms $49.5 Million in Binding Purchase Orders and Aligns Execution with 2026 Regulatory and Deployment Milestones

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions